Financial Daily from THE HINDU group of publications
Saturday, Jun 26, 2004

Cross Currency

Group Sites

Corporate - Announcements

Natco Pharma unveils new drug

Our Bureau

Hyderabad , June 25

NATCO Pharma Ltd has announced the launch of Ganciclovir said to be one of the latest generation drugs used in the treatment and prevention of cytomegalovirus. The drug was launched in 250 mg capsules and 500 ml injection forms.

In a release here on Friday, the company said cytomegalovirus retinitis is a potential threat in immuno-compromised and AIDS patients, patients undergoing chemotherapy and recipients of organ transplants. In these cases, cytomegalovirus could lead to irreparable blindness, the company said.

According to the company, Ganciclovir, on its intake, converts itself to a triphosphate and effectively inhibits DNA polymerases and consequently its replication.

The drug would effectively combat the eyesight threatening infection.

More Stories on : Announcements | New Products & Services | Pharmaceuticals | Health

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Natco Pharma unveils new drug

PSL bags 3 orders worth Rs 300 cr
BPB plans to delist India Gypsum
SAIL, Tata Steel ties strained over Metaljunction portal
Radico to buy entire Bacardi stake in Whytehall
AP Paper Mills to implement Rs 554-cr development plan
Miyazu joins hands with Sumi Motherson group — Design and manufacture of car body dies
Hope, CA set up school for slum kids in Hyderabad
UB group plans low-cost airline by year-end: Mallya
TV18 to offer 1:12 rights; to raise Rs 20 cr
Left plea to merge HOCL unit with Kochi Refineries
Coke India's operational structure still uncertain
DSCL plans to expand farmers' stores network
Amul sales up 18% at Rs 2,882 crore
Parthiv Patel to don gloves for Reliance
Mirchandani quits Weekender; to head S. Kumars' Reid & Taylor

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line